Literature DB >> 32266417

Phosphate Metabolism in Health and Disease.

Munro Peacock1.   

Abstract

Phosphorus, a 5A element with atomic weight of 31, comprises just over 0.6% of the composition by weight of plants and animals. Three isotopes are available for studying phosphorus metabolism and kinetics. 31P is stable, whereas the radioactive isotope 33P has a half-life of 25 days and 32P has a half-life of 14 days. Phosphate ester and phosphoanhydride are common chemical linkages and phosphorus is a key element in organic molecules involved in a wide variety of essential cellular functions. These include biochemical energy transfer via adenosine triphosphate (ATP), maintenance of genetic information with nucleotides DNA and RNA, intracellular signaling via cyclic adenosine monophosphate (cAMP), and membrane structural integrity via glycerophospholipids. However, this review focuses on the metabolism of inorganic phosphorus (Pi) acting as a weak acid. Phosphoric acid has all three hydrogens attached to oxygen and is a weak diprotic acid. It has 3 pKa values: pH 2.2, pH 7.2, and pH 12.7. At physiological pH of 7.4, Pi exists as both H2PO4(-) and HPO4(2-) and acts as an extracellular fluid (ECF) buffer. Pi is the form transported across tissue compartments and cells. Measurement of Pi in biological fluids is based on its reaction with ammonium molybdate which does not measure organic phosphorus. In humans, 80% of the body phosphorus is present in the form of calcium phosphate crystals (apatite) that confer hardness to bone and teeth, and function as the major phosphorus reservoir (Fig. 1). The remainder is present in soft tissues and ECF. Dietary phosphorus, comprising both inorganic and organic forms, is digested in the upper gastrointestinal tract. Absorbed Pi is transported to and from bone, skeletal muscle and soft tissues, and kidney at rates determined by ECF Pi concentration, rate of blood flow, and activity of cell Pi transporters (Fig. 2). During growth, there is net accretion of phosphorus, and with aging, net loss of phosphorus occurs. The bone phosphorus reservoir is depleted and repleted by overall phosphorus requirement. Skeletal muscle is rich in phosphorus used in essential biochemical energy transfer. Kidney is the main regulator of ECF Pi concentration by virtue of having a tubular maximum reabsorptive capacity for Pi (TmPi) that is under close endocrine control. It is also the main excretory pathway for Pi surplus which is passed in urine. Transcellular and paracellular Pi transports are performed by a number of transport mechanisms widely distributed in tissues, and particularly important in gut, bone, and kidney. Pi transporters are regulated by a hormonal axis comprising fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), and 1,25 dihydroxy vitamin D (1,25D). Pi and calcium (Ca) metabolism are intimately interrelated, and clinically neither can be considered in isolation. Diseases of Pi metabolism affect bone as osteomalacia/rickets, soft tissues as ectopic mineralization, skeletal muscle as myopathy, and kidney as nephrocalcinosis and urinary stone formation. Fig. 1 Content of phosphorus in human adult: skeleton, soft tissue, and extracellular fluid (grams, log scale). Corresponding data for calcium are shown for comparison Fig. 2 Phosphate (Pi) transport to and from tissue compartments in mg/24 h. At a dietary phosphorus of 1400 mg, 1120 mg is absorbed in upper intestine to the ECF, 210 mg returned to intestine by endogenous secretion, resulting in 910 mg net Pi absorption and 490 mg fecal excretion. At bone, 180 mg is deposited by bone formation and 180 mg return to the ECF by bone resorption. At kidney, 5040 mg is filtered at the glomerulus and 4130 mg return to the ECF by tubular reabsorption with 910 mg excreted in the urine. In soft tissue, Pi is exchanged between ECF and cells.

Entities:  

Keywords:  Disease; Endocrine regulation; Homeostasis; Metabolism; Phosphate; Transport

Year:  2020        PMID: 32266417     DOI: 10.1007/s00223-020-00686-3

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  93 in total

Review 1.  Serum phosphate abnormalities in the emergency department.

Authors:  Joseph R Shiber; Amal Mattu
Journal:  J Emerg Med       Date:  2002-11       Impact factor: 1.484

Review 2.  Contributions to total phosphorus intake: all sources considered.

Authors:  Mona S Calvo; Jaime Uribarri
Journal:  Semin Dial       Date:  2012-12-23       Impact factor: 3.455

3.  Phosphorus Balance in Adolescent Girls and the Effect of Supplemental Dietary Calcium.

Authors:  Colby J Vorland; Berdine R Martin; Connie M Weaver; Munro Peacock; Kathleen M Hill Gallant
Journal:  JBMR Plus       Date:  2017-11-29

4.  The effects of inheritance on constituents of plasma: a twin study on some biochemical variables.

Authors:  J B Whitfield; N G Martin
Journal:  Ann Clin Biochem       Date:  1984-05       Impact factor: 2.057

Review 5.  Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment.

Authors:  R Subramanian; R Khardori
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

6.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Authors:  G A Block; T E Hulbert-Shearon; N W Levin; F K Port
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

7.  Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

8.  Renal threshold phosphate concentration (TmPO4/GFR).

Authors:  K Kruse; U Kracht; G Göpfert
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

Review 9.  Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.

Authors:  Geoffrey A Block; Joachim H Ix; Markus Ketteler; Kevin J Martin; Ravi I Thadhani; Marcello Tonelli; Myles Wolf; Harald Jüppner; Keith Hruska; David C Wheeler
Journal:  Am J Kidney Dis       Date:  2013-06-12       Impact factor: 8.860

10.  Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects.

Authors:  Kevin J Martin; Gregory Bell; Karen Pickthorn; Saling Huang; Andrew Vick; Peter Hodsman; Munro Peacock
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

View more
  18 in total

1.  Phosphate Metabolism.

Authors:  Salvatore Minisola; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2020-08-09       Impact factor: 4.333

Review 2.  Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.

Authors:  Joana Krämer; Rui Kang; Laura M Grimm; Luisa De Cola; Pierre Picchetti; Frank Biedermann
Journal:  Chem Rev       Date:  2022-01-07       Impact factor: 60.622

Review 3.  Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease.

Authors:  Merita Rroji; Andreja Figurek; Davide Viggiano; Giovambattista Capasso; Goce Spasovski
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 4.  Between a rock and a hard place: Regulation of mineralization in the periodontium.

Authors:  Natalie L Andras; Fatma F Mohamed; Emily Y Chu; Brian L Foster
Journal:  Genesis       Date:  2022-04-23       Impact factor: 2.389

Review 5.  Phylogeny and chemistry of biological mineral transport.

Authors:  Paul H Schlesinger; Demetrios T Braddock; Quitterie C Larrouture; Evan C Ray; Vladimir Riazanski; Deborah J Nelson; Irina L Tourkova; Harry C Blair
Journal:  Bone       Date:  2020-08-26       Impact factor: 4.398

Review 6.  Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism.

Authors:  Volker Schirrmacher
Journal:  Biomedicines       Date:  2020-11-22

7.  Antiepileptic Stiripentol May Influence Bones.

Authors:  Agnieszka Matuszewska; Beata Nowak; Anna Nikodem; Anna Merwid-Ląd; Benita Wiatrak; Tomasz Tomkalski; Diana Jędrzejuk; Ewa Szeląg; Tomasz Sozański; Maciej Danielewski; Paulina Jawień; Ireneusz Ceremuga; Marta Szandruk-Bender; Marek Bolanowski; Jarosław Filipiak; Adam Szeląg
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

8.  Perspective: Plant-based Whole-Grain Foods for Chronic Kidney Disease: The Phytate-Phosphorus Conundrum.

Authors:  Mona S Calvo; Jaime Uribarri
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

Review 9.  Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism.

Authors:  Giovanni Lombardi; Ewa Ziemann; Giuseppe Banfi; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

10.  Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.

Authors:  Anton G Kutikhin; Lian Feenstra; Alexander E Kostyunin; Arseniy E Yuzhalin; Jan-Luuk Hillebrands; Guido Krenning
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.